These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19748367)

  • 21. Subjective side effects of antipsychotics and medication adherence in people with schizophrenia.
    McCann TV; Clark E; Lu S
    J Adv Nurs; 2009 Mar; 65(3):534-43. PubMed ID: 19222651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Sexual problems in patients with schizophrenia].
    Schöttle D; Kammerahl D; Huber J; Briken P; Lambert M; Huber CG
    Psychiatr Prax; 2009 May; 36(4):160-8. PubMed ID: 19424938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of patients' representations and beliefs about diabetes and its treatment on their adherence to therapy.
    Gentili P; Maldonato A; Grieco R; Santini A
    Diabetes Nutr Metab; 2001 Jun; 14(3):140-52. PubMed ID: 11476361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antipsychotic medications, psychological side effects and treatment engagement.
    Jones N
    Issues Ment Health Nurs; 2012 Jul; 33(7):492-3. PubMed ID: 22757602
    [No Abstract]   [Full Text] [Related]  

  • 25. A brief history of depot neuroleptics.
    Simpson GM
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):3-4. PubMed ID: 6143745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Taking child as a partner for his treatment: about drug prescriptions].
    Roche JF; Olliac B
    Arch Pediatr; 2010 Jun; 17(6):684-5. PubMed ID: 20654841
    [No Abstract]   [Full Text] [Related]  

  • 27. Attitudinal barriers to prescribing LAI antipsychotics in the outpatient setting: communicating with patients, families, and caregivers.
    Kane JM
    J Clin Psychiatry; 2014 Dec; 75(12):e33. PubMed ID: 25551245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mental health clinicians' beliefs about medicines, attitudes, and expectations of improved medication adherence in patients.
    Byrne MK; Deane FP; Caputi P
    Eval Health Prof; 2008 Dec; 31(4):390-403. PubMed ID: 18826984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment adherence as a social ability: a case of patients with schizophrenia].
    Baudrant-Boga M; Holtzmann J; Allenet B; Debeauchamp I; Giraud-Baro E
    J Pharm Belg; 2009 Sep; (3):91-8. PubMed ID: 19873850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Applying Motivational Interviewing to the initiation of long-acting injectable atypical antipsychotics.
    Kisely S; Ligate L; Roy MA; Lavery T
    Australas Psychiatry; 2012 Apr; 20(2):138-42. PubMed ID: 22467557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antipsychotic side-effect - potential risk of patients rejecting their treatments.
    Dadić-Hero E; Ruzić K; Medved P; Tatalović-Vorkapić S; Graovac M
    Psychiatr Danub; 2010 Mar; 22(1):105-7. PubMed ID: 20305602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
    Mercier C; Bret P; Bret MC; Queuille E
    Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Patient non-compliance with medication].
    Lagomarsino AJ
    Acta Psiquiatr Psicol Am Lat; 1988 Jun; 34(2):127-34. PubMed ID: 2906212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attitudes of patients and mental health staff to antipsychotic long-acting injections: systematic review.
    Waddell L; Taylor M
    Br J Psychiatry Suppl; 2009 Nov; 52():S43-50. PubMed ID: 19880916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On the path to recovery: patients' experiences of treatment with long-acting injections of antipsychotic medication.
    Svedberg B; Backenroth-Ohsako G; Lützén K
    Int J Ment Health Nurs; 2003 Jun; 12(2):110-8. PubMed ID: 12956022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [25 years antipsychotics: back to the future?].
    Denys D; de Haan L
    Tijdschr Psychiatr; 2008; 50 Spec no.():105-9. PubMed ID: 19067308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Long-acting neuroleptics in the therapeutic relationship. I. General considerations].
    Benvenuti P
    Riv Patol Nerv Ment; 1982; 103(5):235-47. PubMed ID: 6142521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The application of long-acting injectable antipsychotics in clinical practice (overcoming of obstacles)].
    Lutova NB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(10):102-5. PubMed ID: 25591527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-acting neuroleptics and therapeutic relationship.
    Pelc I
    Acta Psychiatr Belg; 1981; 81(2):154-60. PubMed ID: 6117185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prototype approach toward antipsychotic medication adherence in schizophrenia.
    Freudenreich O; Tranulis C
    Harv Rev Psychiatry; 2009; 17(1):35-40. PubMed ID: 19205965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.